Breast cancer screening tests, including mammograms, ultrasounds, and MRIs, were delayed as a result of the COVID-19 pandemic, according to studies presented at the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer.
Read MoreA liquid biopsy is essentially a simple blood test. But that’s not all. With today’s advanced technology we can now examine the blood of cancer patients with unprecedented accuracy and sensitivity to detect important features of the disease that can be extremely helpful to better plan treatment.
Read MoreProtean BioDiagnostics has opened new liquid Biopsy trial in partnership with Epic Sciences for women with recurrent breast cancer in the USA and Canada.
Read MoreDiaceutics announces the establishment of a dedicated Advisory Panel of experts to support and inform the development and rollout of its revolutionary DXRX platform – the world’s first diagnostic network for precision medicine.
Read MoreDiaceutics announces the establishment of a dedicated Advisory Panel of experts to support and inform the development and rollout of its revolutionary DXRX platform – the world’s first diagnostic network for precision medicine.
Read MoreProtean BioDiagnostics is pleased to announce that we are expanding our operations and relocating the head office and laboratories to beautiful new facilities in the Guidewell Center at Medical City in Lake Nona.
Read More
